mardi 2 août 2016

Onco Actu du 2 août 2016

NB : la production d'Onco Actu s'interrompt aujourd'hui et reprendra à partir du 22 août.

1. Biologie


Targeting genes by the thousands [MIT News]


Taking aim at rare cancer variants [Broad Institute of MIT and Harvard]

5. Traitements


Stem Cells May Speed Up Screening of Drugs for Rare Cancers [Johns Hopkins]


Delivering Cancer Drugs to Tumor Blood Vessels [National Cancer Institute]

5.12.2 Immunothérapies - CAR-T


Setting the Body’s ‘Serial Killers’ Loose on Cancer [NY Times]

5.2 Pharma


Layoffs at Takeda [In the Pipeline]


Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma [Takeda]

5.2.3 Pharma - économie


Celgene Accused of Using Charities ‘Scheme’ to Gain Billions [Bloomberg]

5.3 Traitements - FDA, EMA,...


EMA to Cut One Drug Division, Strengthen Collaborations With National Competent Authorities [RAPS]


Identifying opportunities for 'Big data' in medicines development and regulation [EMA]


Ireland calls for EU drug agency to be moved from London to Dublin [The Guardian]

6. Lutte contre les cancers


MD Anderson (Again) On Top of U.S. News and World Report Rankings [The Cancer Letter]

6.6 Publications


BMJ Open works with Publons to give credit for peer review [BMJ Blogs]


‘Kudos’ promises to help scientists promote their papers to new audiences [Nature News & Comment]

6.7 DMP, Big Data & applis


Introducing CancerBase: A Way To Share Personal Medical Data To Help Cancer Research [Scope Blog]


6.9 Controverses


Dispute over president's age tears Pasteur Institute apart [Science]